IND for colon cancer based on this data I believe
Post# of 154087
(Total Views: 347)
Posted On: 05/30/2019 9:22:35 AM
IND for colon cancer based on this data I believe from last year.
I would wow this will work with TNBC. Will they need to do phase1/phase2 for a different chemo drug?
https://www.cytodyn.com/media/press-releases/...ng-pro-140
I would wow this will work with TNBC. Will they need to do phase1/phase2 for a different chemo drug?
https://www.cytodyn.com/media/press-releases/...ng-pro-140
Quote:
VANCOUVER, Washington, Aug. 15, 2018 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), a biotechnology company developing a novel humanized CCR5 monoclonal antibody for multiple therapeutic indications, announces that PRO 140 (leronlimab) has been shown effective at inhibiting the growth of a human colon carcinoma cell line (SW480) in a prominent mouse model. The results were statistically significant and provide the basis for filing an Investigative New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for a clinical trial in colon carcinoma patients.
Two different strains of immunoincompetent mice were used to grow SW480 human tumor cells and different doses of PRO 140 were used in these studies. The SW480 cell line was derived from a patient with colon adenocarcinoma and, like many human cancers, was CCR5-positive. PRO 140 extended the life of treated mice and decreased tumor growth compared to control mice by greater than 50%, which was statistically significant. These results were dose dependent and were repeated in separate experiments. Current ongoing preclinical studies are defining the mechanisms involved in the anti-tumor efficacy of PRO 140.
(0)
(0)